» Articles » PMID: 22937017

Distance from Home to Study Clinic and Risk of Follow-up Interruption in a Cohort of HIV-1-discordant Couples in Nairobi, Kenya

Overview
Journal PLoS One
Date 2012 Sep 1
PMID 22937017
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Longitudinal studies of HIV-1-infected individuals or those at risk of infection are subject to missed study visits that may have negative consequences on the care of participants and can jeopardize study validity due to bias and loss of statistical power. Distance between participant residence and study clinic, as well as other socioeconomic and demographic factors, may contribute to interruptions in patient follow-up.

Methods: HIV-1-serodiscordant couples were enrolled between May 2007 and October 2009 and followed for two years in Nairobi, Kenya. At baseline, demographic and home location information was collected and linear distance from each participant's home to the study clinic was determined. Participants were asked to return to the study clinic for quarterly visits, with follow-up interruptions (FUI) defined as missing two consecutive visits. Cox proportional hazards regression was used to assess crude and adjusted associations between FUI and home-to-clinic distance, and other baseline characteristics.

Results: Of 469 enrolled couples, 64% had a female HIV-1-infected partner. Overall incidence of FUI was 13.4 per 100 person-years (PY), with lower incidence of FUI in HIV-1-infected (10.8 per 100 PY) versus -uninfected individuals (16.1 per 100 PY) (hazard ratio [HR] = 0.66; 95% confidence interval [CI]: 0.50, 0.88). Among HIV-1-infected participants, those living between 5 and 10 kilometers (km) from the study clinic had a two-fold increased rate of FUI compared to those living <5 km away (HR = 2.17; 95% CI: 1.09, 4.34). Other factors associated with FUI included paying higher rent (HR = 1.67; 95% CI: 1.05, 2.65), having at least primary school education (HR = 1.96; 95% CI: 1.02, 3.70), and increased HIV-1 viral load (HR = 1.23 per log(10) increase; 95% CI: 1.01, 1.51).

Conclusions: Home-to-clinic distance, indicators of socioeconomic status, and markers of disease progression may affect compliance with study follow-up schedules. Retention strategies should focus on participants at greatest risk of FUI to ensure study validity.

Citing Articles

Predictors of retention in the prospective HIV prevention OKAPI cohort in Kinshasa.

Carlos S, Burgueno E, Ndarabu A, Reina G, Lopez-Del Burgo C, Osorio A Sci Rep. 2021; 11(1):5431.

PMID: 33686218 PMC: 7970874. DOI: 10.1038/s41598-021-84839-w.


Retention of adults from fishing communities in an HIV vaccine preparedness study in Masaka, Uganda.

Bahemuka U, Abaasa A, Ruzagira E, Lindan C, Price M, Kamali A PLoS One. 2019; 14(1):e0198460.

PMID: 30640918 PMC: 6331119. DOI: 10.1371/journal.pone.0198460.


HIV viral suppression and geospatial patterns of HIV antiretroviral therapy treatment facility use in Rakai, Uganda.

Billioux V, Grabowski M, Ssekasanvu J, Reynolds S, Berman A, Bazaale J AIDS. 2018; 32(6):819-824.

PMID: 29369167 PMC: 5854528. DOI: 10.1097/QAD.0000000000001761.


Effects of patient load and travel distance on HIV transmission in rural China: Implications for treatment as prevention.

Smith M, Miller W, Liu H, Ning C, He W, Cohen M PLoS One. 2017; 12(5):e0177976.

PMID: 28562661 PMC: 5451043. DOI: 10.1371/journal.pone.0177976.


Understanding Sustained Retention in HIV/AIDS Care and Treatment: a Synthetic Review.

Roy M, Czaicki N, Holmes C, Chavan S, Tsitsi A, Odeny T Curr HIV/AIDS Rep. 2016; 13(3):177-85.

PMID: 27188300 DOI: 10.1007/s11904-016-0317-9.


References
1.
Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H . Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009; 9:290. PMC: 2734853. DOI: 10.1186/1471-2458-9-290. View

2.
Touloumi G, Pocock S, Babiker A, Darbyshire J . Impact of missing data due to selective dropouts in cohort studies and clinical trials. Epidemiology. 2002; 13(3):347-55. DOI: 10.1097/00001648-200205000-00017. View

3.
Roura M, Busza J, Wringe A, Mbata D, Urassa M, Zaba B . Barriers to sustaining antiretroviral treatment in Kisesa, Tanzania: a follow-up study to understand attrition from the antiretroviral program. AIDS Patient Care STDS. 2009; 23(3):203-10. PMC: 2776987. DOI: 10.1089/apc.2008.0129. View

4.
Snow W, Connett J, Sharma S, Murray R . Predictors of attendance and dropout at the Lung Health Study 11-year follow-up. Contemp Clin Trials. 2006; 28(1):25-32. PMC: 2562880. DOI: 10.1016/j.cct.2006.08.010. View

5.
Rosen S, Fox M, Gill C . Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007; 4(10):e298. PMC: 2020494. DOI: 10.1371/journal.pmed.0040298. View